Advisory Board
GHB Intellect’s advisory board is comprised of industry thought leaders with decades of experience. Their knowledge and expertise contribute immensely to GHB Intellect, helping to provide unparalleled value to our clients.
Ross Farahani, PhD
Dr. Farahani received his PhD degree in Materials Science and Engineering in 1980. Over the past 27 years he has been employed by several of the semiconductor industry leaders (United Technologies Mostek, SGS Thompson, AMD, and Intel), where he was instrumental in the development and integration of multiple innovative processes in semiconductors device fabrication and packaging assembly. Many of the processes are still in production. His work experience encompasses interconnect process technology development and integration for DRAM, Flash nonvolatile memory, microprocessor, and high voltage Bipolar. While at AMD, he also managed the integration group responsible for interconnect technology research, development, and integration for high voltage bipolar technology. Dr. Farahani was an AMD Technical Fellow and has numerous publications and patents in semiconductor interconnect metallization.
Graham Beaton, PhD
Dr. Beaton is a life sciences entrepreneur engaged in developing new product opportunities in healthcare and bolsters the GHB Intellect technology development service offering. He is President and co-founder of Epigen Biosciences Inc., a project incubator located in San Diego and co-founder and acting Chief Science Officer at Curtana Pharmaceuticals, an early-stage startup engaged in the discovery and development of novel targeted treatments for glioblastoma and other brain cancers. Dr. Beaton has gained more than 20 years working experience in the healthcare sector with respect to pharmaceuticals and biotechnology from companies including Amgen, DuPont Pharmaceuticals and Neurocrine Biosciences.
Hossein Rahbar, PhD
Prof. Rahbar obtained his PhD degree in Statistics from Michigan State University (MSU) in East Lansing, Michigan, in 1988. In 2008, Dr. Rahbar joined the University of Texas Health Science Center at Houston (UTHealth) as Professor of Epidemiology and Biostatistics in the School of Public Health. He also serves as Director, Biostatistics/Epidemiology/Research Design (BERD) component of Center for Clinical and Translational Sciences (CCTS) at UTHealth. In 2012, Prof. Rahbar was appointed as the founding Director of the Division of Clinical and Translational Sciences (DCTS) in the Department of Internal Medicine at UTHealth.
Currently, he is a tenured professor in Internal Medicine and the School of Public Health. Prof. Rahbar is a member of several professional organizations including Joint Statistical Meeting (JSM), American Statistical Association (ASA), Society of Epidemiological Research (SER), International Society for Autism Research (INSAR), Canadian-USA Clinical Epidemiology Network, Pulmonary Vascular Research Institute. He serves as a member of Advisory Group to the World Health Organization (WHO) regarding Maternal and Perinatal Health Research and Reproductive Epidemiology. He is Editor-in-Chief of American Journal of Autism (AJA) and recipient of several prestigious grant awards from NICHD, NIEHS, NHLBI, NINDS, DoD, and WHO.
Farah Babakhani, PhD
Dr. Babakhani has 20 years of experience in pharmaceutical industry and diagnostic laboratory management. She was a key contributor to the microbiological development of the recently approved Fidaxomicin antibiotic and contributed to pre-clinical development of other anti-infectives. Her contributions have led to several peer-reviewed publications and patent authorships. Prior to working in the pharmaceutical industry, Dr. Babakhani managed a diagnostic clinical microbiology laboratory.